Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance
König, C.; Both, A.; Rohde, H.; Kluge, S.; Frey, O.R.; Röhr, A.C.; Wichmann, D. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics 2021, 10, 649. https://doi.org/10.3390/antibiotics10060649
König C, Both A, Rohde H, Kluge S, Frey OR, Röhr AC, Wichmann D. Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance. Antibiotics. 2021; 10(6):649. https://doi.org/10.3390/antibiotics10060649
Chicago/Turabian StyleKönig, Christina, Anna Both, Holger Rohde, Stefan Kluge, Otto R. Frey, Anka C. Röhr, and Dominic Wichmann. 2021. "Cefiderocol in Critically Ill Patients with Multi-Drug Resistant Pathogens: Real-Life Data on Pharmacokinetics and Microbiological Surveillance" Antibiotics 10, no. 6: 649. https://doi.org/10.3390/antibiotics10060649